Investment Rating - The report maintains a "Buy" investment rating for the company [1][8] Core Views - The company's operational trends are improving, leading to a release in profitability [1] - In 2024, total revenue reached 3.835 billion yuan, a year-on-year increase of 10%, while net profit attributable to shareholders was 268 million yuan, up 267% [4][8] - The company is focusing on cost control and efficiency improvements, with a slight recovery in gross margin expected [5][8] Financial Performance - In Q4 2024, total revenue was 1.118 billion yuan, a 22% year-on-year increase, and net profit was 65 million yuan, compared to a loss of 85 million yuan in Q4 2023 [4] - For Q1 2025, total revenue was 1.046 billion yuan, a 14% year-on-year increase, with net profit of 88 million yuan, up 15% [4] - The gross margin for 2024 and Q1 2025 was 31.47% and 29.99%, respectively, reflecting changes in channel and product structure [5] Product and Channel Strategy - The company is expanding its product matrix in the cream category, with significant growth in UHT cream products [6][8] - Revenue from the cream segment in 2024 was 1.058 billion yuan, a 62% increase year-on-year [6] - The company is actively exploring new channel opportunities and has seen good sales performance from new products launched in supermarkets [7] Profit Forecast - The company is expected to see continued profit recovery, with EPS projected at 1.97 yuan for 2025, 2.31 yuan for 2026, and 2.75 yuan for 2027 [8][10] - The current stock price corresponds to a PE ratio of 19 for 2025, 16 for 2026, and 14 for 2027 [8]

成都先导（688222.SH）2024 年报&2025 年一季报点评 行稳则致远，AI 再创星辰大海 2025 年 04 月 29 日 ➢ 事件：2025 年 4 月 26 日，成都先导发布 2024 年年报及 2025 年一季报业 绩。2024 年公司实现营业收入 4.27 亿元，同比上升 14.99%；归母净利润 0.51 亿元，同比上升26.13%。2025Q1公司实现营业收入1.07亿元，同比下滑0.60%， 归母净利润 0.28 亿元，同比上升 102.90%。 ➢ 毛利率持续改善，25Q1 利润端提升明显。单季度来看，公司 25Q1 收入 1.07 亿元，同比-0.60%，主要系英国子公司 Vernalis Limited 获得涉及或有对 价的项目里程碑收入减少，剔除此部分集团同比增长 8%，归母净利润 0.28 亿 元，同比+102.90%，主要系剔除 Vernalis 里程碑收入后的主营业务毛利率增加， 政府补助同比增加以及汇兑收益增加等。25Q1 公司毛利率 48.13%，同比 +2.92pcts，环比+5.83pcts，提升明显。费用端，25Q1 公司研发费用率 12.01%， 同比-0. ...

公司发布 2024 年年报以及 2025 年 1 季报，2024 年全年公司实现 营收 104.35 亿元，同比-9.09%；实现归母净利润 12.02 亿元，同 比-23.19%。2025年1季度，公司实现收入32.41亿元，同比+2.04%， 实现归母净利润 4.35 亿元，同比+1.35%。 2024 年度，公司销售费用 2.32 亿元，同比+0.99%；管理费用 4.68 亿元，同比-9.60%，主要是排污费下降；财务费用-0.65 亿元，同 比-11.35%，主要是由于利息收入同比增加；研发费 3.58 亿元， 同比-14.32%，主要是研发领用的材料价格下降，致研发费用成本 下降。 分业务来看，2025 年 1 季度，公司原药产量 2.95 万吨，销量 2.87 万吨，价格 6.30 万元/吨，同比-8.83%；制剂产量 1.30 万吨，销 量 1.54 万吨，价格 5.66 万元/吨，同比-1.57%。2024 年全年，公 司原药产量 9.69 万吨，销量 9.99 万吨，价格 6.43 万元/吨；制 剂产量 3.54 万吨，销量 3.64 万吨，价格 4.25 万元/吨。 葫芦岛项目投资为公司 ...

Investment Rating - The report maintains a "Buy" rating for the company, with a target price based on the last closing price of 49.00 [1] Core Insights - The company achieved significant breakthroughs in its pre-installation business, leading to rapid profit growth in Q1 2025 [1][6] - In 2025, the company reported total revenue of 2.777 billion yuan, a year-on-year increase of 63.45%, and a net profit attributable to shareholders of 290 million yuan, up 184.50% year-on-year [4][7] - The company's main business revenue reached 1.974 billion yuan in 2025, growing by 32.73%, with overseas revenue showing a remarkable increase of 44.99% [5] Financial Performance - The company’s gross profit margin improved to 47.95%, an increase of 2.85 percentage points year-on-year [5] - R&D expenses for 2024 were 284 million yuan, a 15.14% increase, while the R&D expense ratio decreased from 16.57% in 2023 to 14.37% in 2024 [5] - The company’s Q1 2025 gross margin was 47.71%, reflecting a year-on-year increase of 5.49 percentage points [5] Revenue Forecast - The company is projected to achieve revenues of 2.634 billion yuan, 3.394 billion yuan, and 4.242 billion yuan for 2025, 2026, and 2027 respectively, with net profits of 413 million yuan, 590 million yuan, and 797 million yuan for the same years [6][7]

瑞丰银行(601528) 报告日期：2025 年 04 月 28 日 盈利显韧性 ——瑞丰银行 2025 年一季报点评 投资要点 ❑ 瑞丰银行 2025Q1 盈利韧性显现，息差小幅回升，其他非息拖累。 ❑ 业绩概览 瑞丰银行 2025Q1 营收同比增长 5.1%，增速较 24A 放缓 10.2pc；归母净利润同比 增长 6.7%，增速较 24A放缓 4.6pc。2025Q1末不良率环比持平于 0.97%；2025Q1 末拨备覆盖率 326%，较 24A 末上升 5.2pc。 ❑ 营收降幅收窄 瑞丰银行 2025Q1 营收同比增长 5.1%，增速较 24A 放缓 10.2pc；归母净利润同 比增长 6.7%，增速较 24A 放缓 4.6pc。驱动因素来看，规模扩张放缓和其他非息 波动拖累营收增速放缓。①规模，25Q1 末总资产同比增长 11.1%，增速较 24A 末放缓 0.9pc。25Q1 末贷款同比增长 11.7%，增速较 24A 末放缓 3.8pc，贷款投 放动能边际减弱。②息差，25Q1 单季息差（期初期末口径，下同）为 1.45%， 环比上升 5bp，息差回暖对营收形成支撑。③非息，25Q1 其他非息 ...

Investment Rating - The report maintains an "Accumulate" rating for the company [1] Core Views - The company has shown steady performance with a diversified layout contributing to growth in 2024 and Q1 2025, driven by recovery in consumer electronics, automotive, and dental medical sectors [5][6] - The company achieved a revenue of 4 billion CNY in 2024, a year-on-year increase of 5%, and a net profit of 600 million CNY, up 6% year-on-year [5] - In Q1 2025, the company reported a revenue of 975 million CNY, an 18% increase year-on-year, and a net profit of 136 million CNY, a 2% increase year-on-year [5] Summary by Sections Financial Performance - In 2024, the company’s revenue was 40 billion CNY, with a net profit of 6 billion CNY, while Q4 alone contributed 10.8 billion CNY in revenue [5] - The Q1 2025 results showed a revenue of 9.75 billion CNY and a net profit of 1.36 billion CNY [5] Business Segments - The electronic materials segment benefited from recovering downstream demand, with MLCC medium powder sales gradually increasing [6] - The catalytic materials segment successfully overcame technical barriers, meeting stringent vehicle emission standards, and saw rapid growth in sales due to increased demand from overseas clients [6] - The biomedical segment received EU medical device compliance certification for several products, enhancing market recognition and paving the way for accelerated promotion in Europe [6] Growth Opportunities - The company is strategically positioned in the new energy sector, launching several lithium battery additives and becoming a major supplier in the industry [7] - The LED substrate segment has strengthened its competitive edge through technological synergies, while the communication RF micro-system chip packaging business is expected to become a significant growth point [7] - The subsidiary has made strides in digital printing materials, aiming to become a leader in the Chinese market [7] Profitability and Valuation - The report adjusts the profit forecasts for 2025-2026 downwards by 20%, with expected net profits of 754 million CNY and 914 million CNY respectively, while introducing a forecast for 2027 at 1.13 billion CNY [8][9] - The company’s EPS is projected to be 0.76 CNY for 2025, 0.92 CNY for 2026, and 1.13 CNY for 2027 [8][9]

当前价：13.52 元 作者 分析师：陈彦彤 执业证书编号：S0930518070002 021-52523689 chenyt@ebscn.com 2025 年 4 月 29 日 公司研究 24 年复调与轻烹业务增长稳健，持续完善产品矩阵与新渠道布局 ——宝立食品（603170.SH）2024 年年报与 25 年一季报点评 增持（维持） 分析师：汪航宇 执业证书编号：S0930523070002 021-52523174 wanghangyu@ebscn.com 分析师：聂博雅 执业证书编号：S0930522030003 021-52523808 nieboya@ebscn.com | 市场数据 | | | --- | --- | | 总股本(亿股) | 4.00 | | 总市值(亿元)： | 54.08 | | 一年最低/最高(元)： | 10.31/17.45 | | 近 3 月换手率： | 48.52% | 股价相对走势 要点 事件：公司发布 2024 年年报，24 年实现营收/归母净利润分别为 26.51/2.33 亿元， 分别同比+11.9%/-22.5%。24Q4 实现营收/归母净利润分别为 7 ...

Investment Rating - The report maintains a "Buy" rating for the company with a target price of 13.86, compared to the last closing price of 10.97 [1]. Core Views - The company's performance is currently affected by a downturn in the tank container industry, but it is actively expanding its product lines to enhance competitiveness [5][8]. - The company reported a revenue of 1.863 billion yuan for 2024, a year-on-year decline of 16.41%, and a net profit of 237 million yuan, down 28.91% year-on-year [4][6]. - The tank container business generated 1.092 billion yuan in revenue, a decrease of 27.47% year-on-year, primarily due to the industry being in a down cycle [5]. - The cold chain equipment segment showed stable growth, achieving a revenue of 720 million yuan, an increase of 10.86% year-on-year [5]. Financial Summary - The company’s comprehensive gross margin for 2024 was 24.45%, a slight decrease of 0.9 percentage points year-on-year [6]. - The projected revenues for 2025 to 2027 are 1.952 billion yuan, 2.095 billion yuan, and 2.323 billion yuan, respectively, with corresponding net profits of 239 million yuan, 249 million yuan, and 286 million yuan [7]. - The earnings per share (EPS) are expected to be 0.77 yuan for 2025, 0.81 yuan for 2026, and 0.92 yuan for 2027 [7].

Investment Rating - The report maintains a "Buy" rating for the company, indicating an expected relative increase of over 15% compared to the CSI 300 index in the next six months [11]. Core Insights - The company reported a significant increase in revenue and net profit for 2024, with operating income reaching 7.36 billion, up 27.69% year-on-year, and net profit attributable to shareholders at 1.10 billion, up 584.21% year-on-year [2][5]. - The first quarter of 2025 also showed strong performance, with operating income of 1.91 billion, a year-on-year increase of 17.32%, and net profit of 235 million, up 14.57% year-on-year [2]. - The company's diverse product lines, including storage chips, microcontrollers, and sensors, have all shown robust growth, driven by strong demand in consumer electronics and advancements in AI technology [3]. Summary by Sections Financial Performance - In 2024, the company achieved operating income of 7.36 billion and net profit of 1.10 billion, with a remarkable net profit growth rate of 584.21% [2][5]. - For Q1 2025, the company reported operating income of 1.91 billion and net profit of 235 million, reflecting a year-on-year growth of 17.32% and 14.57% respectively [2]. Product Performance - The revenue breakdown for 2024 shows storage chips at 5.19 billion, microcontrollers at 1.71 billion, and sensors at 448 million, with growth rates of 27.39%, 29.56%, and 27.20% respectively [3]. - The company's NOR Flash products have seen significant growth across various sectors, including consumer electronics and automotive, achieving record-high shipment volumes [3]. Future Projections - Revenue projections for 2025 to 2027 are 9.49 billion, 11.54 billion, and 13.72 billion, with expected growth rates of 29.00%, 21.65%, and 18.89% respectively [3][5]. - Net profit forecasts for the same period are 1.53 billion, 2.07 billion, and 2.61 billion, with growth rates of 38.83%, 35.49%, and 26.09% respectively [3][5].

证券研究报告|公司点评报告 [Table_Date] 2025 年 04 月 28 日 [Table_Title] 25Q1 业绩接近翻倍，超市场预期 [Table_Title2] 浙江正特(001238) | [Table_DataInfo] 评级： | 买入 | 股票代码： | 001238 | | --- | --- | --- | --- | | 上次评级： | 买入 | 52 周最高价/最低价： | 33.85/19.09 | | 目标价格： | | 总市值(亿) | 32.80 | | 最新收盘价： | 29.82 | 自由流通市值(亿) | 9.54 | | | | 自由流通股数(百万) | 31.98 | [Table_Summary] 事件概述 24 年公司收入/归母净利/扣非归母净利/经营性现金流分别为 12.37/-0.14/-0.08/0.12 亿元，同比增长 13.35%/-182.70%/-126.64%/-80.62%，经营业绩下降的原因在于销售费用及管理费用增加。非经主要为汇兑及 理财产品投资亏损 0.11 亿元；经营性现金流高于归母净利主要由于经营性应付项目增加。24Q4 公 ...